How the Serotonin Story is Being Rewritten by New Gene-based Discoveries Principally Related to SLC6A4, the Serotonin Transporter Gene, Which Functions to Influence All Cellular Serotonin Systems

Overview

Journal Neuropharmacology

Specialties Neurology
Pharmacology

Date 2008 Oct 1

PMID 18824000

Citations 91

Authors

Dennis L Murphy

Meredith A Fox

Kiara R Timpano

Pablo R Moya

Renee Ren-Patterson

Anne M Andrews

Andrew Holmes

Klaus-Peter Lesch

Jens R Wendland

Affiliations

Soon will be listed here.

Abstract

Discovered and crystallized over sixty years ago, serotonin's important functions in the brain and body were identified over the ensuing years by neurochemical, physiological and pharmacological investigations. This 2008 M. Rapport Memorial Serotonin Review focuses on some of the most recent discoveries involving serotonin that are based on genetic methodologies. These include examples of the consequences that result from direct serotonergic gene manipulation (gene deletion or overexpression) in mice and other species; an evaluation of some phenotypes related to functional human serotonergic gene variants, particularly in SLC6A4, the serotonin transporter gene; and finally, a consideration of the pharmacogenomics of serotonergic drugs with respect to both their therapeutic actions and side effects. The serotonin transporter (SERT) has been the most comprehensively studied of the serotonin system molecular components, and will be the primary focus of this review. We provide in-depth examples of gene-based discoveries primarily related to SLC6A4 that have clarified serotonin's many important homeostatic functions in humans, non-human primates, mice and other species.

Citing Articles

Contribution of the serotonergic system to developmental brain abnormalities in autism spectrum disorder.

Wegiel J, Chadman K, London E, Wisniewski T, Wegiel J Autism Res. 2024; 17(7):1300-1321.

PMID: 38500252 PMC: 11272444. DOI: 10.1002/aur.3123.

Serotonin and the serotonin transporter in the adrenal gland.

Bauer M, Currie K Vitam Horm. 2024; 124:39-78.

PMID: 38408804 PMC: 11217909. DOI: 10.1016/bs.vh.2023.06.002.

Sex influences the effects of social status on socioemotional behavior and serotonin neurochemistry in rhesus monkeys.

Wakeford A, Nye J, Grieb Z, Voisin D, Mun J, Huhman K Biol Sex Differ. 2023; 14(1):75.

PMID: 37898775 PMC: 10613371. DOI: 10.1186/s13293-023-00562-3.

Serotonin Transporter (5-Hydroxytryptamine Transporter, SERT, SLC6A4) and Sodium-dependent Reuptake Inhibitors as Modulators of Pain Behaviors and Analgesic Responses.

Huang C, van Wijnen A, Im H J Pain. 2023; 25(3):618-631.

PMID: 37852405 PMC: 11781314. DOI: 10.1016/j.jpain.2023.10.008.

Molecular biology of serotonergic systems in avian brains.

Fujita T, Aoki N, Mori C, Homma K, Yamaguchi S Front Mol Neurosci. 2023; 16:1226645.

PMID: 37538316 PMC: 10394247. DOI: 10.3389/fnmol.2023.1226645.

References

Murphy D, Brodie H, Goodwin F, Bunney Jr W . Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients. Nature. 1971; 229(5280):135-6. DOI: 10.1038/229135a0. View

Maciag D, Simpson K, Coppinger D, Lu Y, Wang Y, Lin R . Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology. 2005; 31(1):47-57. PMC: 3118509. DOI: 10.1038/sj.npp.1300823. View

Kent L, Doerry U, Hardy E, Parmar R, Gingell K, Hawi Z . Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol Psychiatry. 2002; 7(8):908-12. DOI: 10.1038/sj.mp.4001100. View

Pezawas L, Meyer-Lindenberg A, Goldman A, Verchinski B, Chen G, Kolachana B . Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol Psychiatry. 2008; 13(7):709-16. DOI: 10.1038/mp.2008.32. View

Rousseva A, Henry C, Van den Bulke D, Fournier G, Laplanche J, Leboyer M . Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. Pharmacogenomics J. 2003; 3(2):101-4. DOI: 10.1038/sj.tpj.6500156. View

Schmitt A, Benninghoff J, Moessner R, Rizzi M, Paizanis E, Doenitz C . Adult neurogenesis in serotonin transporter deficient mice. J Neural Transm (Vienna). 2007; 114(9):1107-19. DOI: 10.1007/s00702-007-0724-6. View

Rapport M . The discovery of serotonin. Perspect Biol Med. 1997; 40(2):260-73. DOI: 10.1353/pbm.1997.0040. View

Rudnick G . Structure/function relationships in serotonin transporter: new insights from the structure of a bacterial transporter. Handb Exp Pharmacol. 2006; (175):59-73. DOI: 10.1007/3-540-29784-7_3. View

Insel T, Roy B, Cohen R, Murphy D . Possible development of the serotonin syndrome in man. Am J Psychiatry. 1982; 139(7):954-5. DOI: 10.1176/ajp.139.7.954. View

10.

Qu Y, Villacreses N, Murphy D, Rapoport S . 5-HT2A/2C receptor signaling via phospholipase A2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl). 2005; 180(1):12-20. DOI: 10.1007/s00213-005-2231-5. View

11.

Wendland J, DeGuzman T, McMahon F, Rudnick G, Detera-Wadleigh S, Murphy D . SERT Ileu425Val in autism, Asperger syndrome and obsessive-compulsive disorder. Psychiatr Genet. 2008; 18(1):31-9. DOI: 10.1097/YPG.0b013e3282f08a06. View

12.

Neale B, Sham P . The future of association studies: gene-based analysis and replication. Am J Hum Genet. 2004; 75(3):353-62. PMC: 1182015. DOI: 10.1086/423901. View

13.

Mazzanti C, Lappalainen J, Long J, Bengel D, Naukkarinen H, Eggert M . Role of the serotonin transporter promoter polymorphism in anxiety-related traits. Arch Gen Psychiatry. 1998; 55(10):936-40. DOI: 10.1001/archpsyc.55.10.936. View

14.

Haney E, Chan B, Diem S, Ensrud K, Cauley J, Barrett-Connor E . Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007; 167(12):1246-51. DOI: 10.1001/archinte.167.12.1246. View

15.

Laruelle M, Vanisberg M, Maloteaux J . Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites. Biol Psychiatry. 1988; 24(3):299-309. DOI: 10.1016/0006-3223(88)90198-9. View

16.

Meredith E, Holder M, Chamba A, Challa A, Drake-Lee A, Bunce C . The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics. FASEB J. 2005; 19(9):1187-9. DOI: 10.1096/fj.04-3477fje. View

17.

Liu M, Rayport S, Jiang Y, Murphy D, Gershon M . Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter. Am J Physiol Gastrointest Liver Physiol. 2002; 283(6):G1398-411. DOI: 10.1152/ajpgi.00203.2002. View

18.

Oquendo M, Hastings R, Huang Y, Simpson N, Ogden R, Hu X . Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry. 2007; 64(2):201-8. PMC: 3767993. DOI: 10.1001/archpsyc.64.2.201. View

19.

Hariri A, Mattay V, Tessitore A, Kolachana B, Fera F, Goldman D . Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002; 297(5580):400-3. DOI: 10.1126/science.1071829. View

20.

Murphy V, Claffey E, Bergin P, McAuliffe M, Kealey C, McKeon P . Search for bipolar disorder susceptibility loci: the application of a modified genome scan concentrating on gene-rich regions. Am J Med Genet. 2000; 96(6):728-32. DOI: 10.1002/1096-8628(20001204)96:6<728::aid-ajmg6>3.0.co;2-9. View